Cryo Cell International (CCEL) Long-Term Deferred Tax: 2010-2025
Historic Long-Term Deferred Tax for Cryo Cell International (CCEL) over the last 14 years, with Q3 2025 value amounting to $20.8 million.
- Cryo Cell International's Long-Term Deferred Tax rose 150.92% to $20.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $20.8 million, marking a year-over-year increase of 150.92%. This contributed to the annual value of $20.8 million for FY2024, which is 150.92% up from last year.
- Per Cryo Cell International's latest filing, its Long-Term Deferred Tax stood at $20.8 million for Q3 2025, which was up 150.92% from $20.8 million recorded in Q2 2025.
- Cryo Cell International's Long-Term Deferred Tax's 5-year high stood at $20.8 million during Q4 2024, with a 5-year trough of $10.4 million in Q1 2021.
- In the last 5 years, Cryo Cell International's Long-Term Deferred Tax had a median value of $13.7 million in 2022 and averaged $15.8 million.
- In the last 5 years, Cryo Cell International's Long-Term Deferred Tax soared by 4912.06% in 2023 and then soared by 150.92% in 2024.
- Quarter analysis of 5 years shows Cryo Cell International's Long-Term Deferred Tax stood at $12.0 million in 2021, then grew by 14.42% to $13.7 million in 2022, then surged by 49.12% to $20.5 million in 2023, then increased by 1.51% to $20.8 million in 2024, then changed by 0.0% to $20.8 million in 2025.
- Its Long-Term Deferred Tax was $20.8 million in Q3 2025, compared to $20.8 million in Q2 2025 and $20.8 million in Q1 2025.